Cargando…
Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors?
BACKGROUND: The migraine premonitory phase is characterized in part by increased thirst, urination and yawning. Imaging studies show that the hypothalamus is activated in the premonitory phase. Stress is a well know migraine initiation factor which was demonstrated to engage dynorphin/kappa opioid r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524131/ https://www.ncbi.nlm.nih.gov/pubmed/36175828 http://dx.doi.org/10.1186/s10194-022-01497-7 |
_version_ | 1784800438663512064 |
---|---|
author | Kopruszinski, Caroline M. Vizin, Robson Watanabe, Moe Martinez, Ashley L. de Souza, Luiz Henrique Moreira Dodick, David W. Porreca, Frank Navratilova, Edita |
author_facet | Kopruszinski, Caroline M. Vizin, Robson Watanabe, Moe Martinez, Ashley L. de Souza, Luiz Henrique Moreira Dodick, David W. Porreca, Frank Navratilova, Edita |
author_sort | Kopruszinski, Caroline M. |
collection | PubMed |
description | BACKGROUND: The migraine premonitory phase is characterized in part by increased thirst, urination and yawning. Imaging studies show that the hypothalamus is activated in the premonitory phase. Stress is a well know migraine initiation factor which was demonstrated to engage dynorphin/kappa opioid receptors (KOR) signaling in several brain regions, including the hypothalamus. This study proposes the exploration of the possible link between hypothalamic KOR and migraine premonitory symptoms in rodent models. METHODS: Rats were treated systemically with the KOR agonist U-69,593 followed by yawning and urination monitoring. Apomorphine, a dopamine D1/2 agonist, was used as a positive control for yawning behaviors. Urination and water consumption following systemic administration of U-69,593 was also assessed. To examine if KOR activation specifically in the hypothalamus can promote premonitory symptoms, AAV8-hSyn-DIO-hM4Di (Gi-DREADD)-mCherry viral vector was microinjected into the right arcuate nucleus (ARC) of female and male KOR(CRE) or KOR(WT) mice. Four weeks after the injection, clozapine N-oxide (CNO) was administered systemically followed by the assessment of urination, water consumption and tactile sensory response. RESULTS: Systemic administration of U-69,593 increased urination but did not produce yawning in rats. Systemic KOR agonist also increased urination in mice as well as water consumption. Cell specific Gi-DREADD activation (i.e., inhibition through Gi-coupled signaling) of KOR(CRE) neurons in the ARC also increased water consumption and the total volume of urine in mice but did not affect tactile sensory responses. CONCLUSION: Our studies in rodents identified the KOR in a hypothalamic region as a mechanism that promotes behaviors consistent with clinically-observed premonitory symptoms of migraine, including increased thirst and urination but not yawning. Importantly, these behaviors occurred in the absence of pain responses, consistent with the emergence of the premonitory phase before the headache phase. Early intervention for preventive treatment even before the headache phase may be achievable by targeting the hypothalamic KOR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-022-01497-7. |
format | Online Article Text |
id | pubmed-9524131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-95241312022-10-01 Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? Kopruszinski, Caroline M. Vizin, Robson Watanabe, Moe Martinez, Ashley L. de Souza, Luiz Henrique Moreira Dodick, David W. Porreca, Frank Navratilova, Edita J Headache Pain Research BACKGROUND: The migraine premonitory phase is characterized in part by increased thirst, urination and yawning. Imaging studies show that the hypothalamus is activated in the premonitory phase. Stress is a well know migraine initiation factor which was demonstrated to engage dynorphin/kappa opioid receptors (KOR) signaling in several brain regions, including the hypothalamus. This study proposes the exploration of the possible link between hypothalamic KOR and migraine premonitory symptoms in rodent models. METHODS: Rats were treated systemically with the KOR agonist U-69,593 followed by yawning and urination monitoring. Apomorphine, a dopamine D1/2 agonist, was used as a positive control for yawning behaviors. Urination and water consumption following systemic administration of U-69,593 was also assessed. To examine if KOR activation specifically in the hypothalamus can promote premonitory symptoms, AAV8-hSyn-DIO-hM4Di (Gi-DREADD)-mCherry viral vector was microinjected into the right arcuate nucleus (ARC) of female and male KOR(CRE) or KOR(WT) mice. Four weeks after the injection, clozapine N-oxide (CNO) was administered systemically followed by the assessment of urination, water consumption and tactile sensory response. RESULTS: Systemic administration of U-69,593 increased urination but did not produce yawning in rats. Systemic KOR agonist also increased urination in mice as well as water consumption. Cell specific Gi-DREADD activation (i.e., inhibition through Gi-coupled signaling) of KOR(CRE) neurons in the ARC also increased water consumption and the total volume of urine in mice but did not affect tactile sensory responses. CONCLUSION: Our studies in rodents identified the KOR in a hypothalamic region as a mechanism that promotes behaviors consistent with clinically-observed premonitory symptoms of migraine, including increased thirst and urination but not yawning. Importantly, these behaviors occurred in the absence of pain responses, consistent with the emergence of the premonitory phase before the headache phase. Early intervention for preventive treatment even before the headache phase may be achievable by targeting the hypothalamic KOR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-022-01497-7. Springer Milan 2022-09-30 /pmc/articles/PMC9524131/ /pubmed/36175828 http://dx.doi.org/10.1186/s10194-022-01497-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kopruszinski, Caroline M. Vizin, Robson Watanabe, Moe Martinez, Ashley L. de Souza, Luiz Henrique Moreira Dodick, David W. Porreca, Frank Navratilova, Edita Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
title | Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
title_full | Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
title_fullStr | Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
title_full_unstemmed | Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
title_short | Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
title_sort | exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524131/ https://www.ncbi.nlm.nih.gov/pubmed/36175828 http://dx.doi.org/10.1186/s10194-022-01497-7 |
work_keys_str_mv | AT kopruszinskicarolinem exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT vizinrobson exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT watanabemoe exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT martinezashleyl exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT desouzaluizhenriquemoreira exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT dodickdavidw exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT porrecafrank exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors AT navratilovaedita exploringtheneurobiologyofthepremonitoryphaseofmigrainepreclinicallyaroleforhypothalamickappaopioidreceptors |